Common variable immunodeficiency
Also known as: CVID, Common variable immune deficiency, Common variable hypogammaglobulinaemia
Common variable immunodeficiency (CVID) is a heterogeneous primary immunodeficiency characterised by impaired antibody production and recurrent sinopulmonary infections. Sequelae frequently include bronchiectasis, gastrointestinal dysfunction, autoimmunity, and lymphoproliferative disorders. Primary management requires specialist immunology-led care involving immunoglobulin replacement therapy, rigorous infection control, and longitudinal surveillance. Traditional Chinese Medicine (TCM) serves as an adjunctive framework for symptomatic support but does not address the fundamental immunological deficit. Existing clinical data do not provide empirical evidence for the efficacy of acupuncture or the specified herbal formulae in CVID. The review on bronchiectasis [1] pertains to secondary complications rather than the primary CVID aetiology; molecular investigations into COPD [2] and PLCG2 pathways [4] have not established clinical patient outcomes. Furthermore, the review regarding temporomandibular rehabilitation [3] remains irrelevant to CVID management. Listed patterns represent traditional diagnostic classifications and are not equivalent to biomedical phenotypes.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to all immunology consultations and prescribed replacement therapies; ensure the infectious disease action plan is readily accessible.
- •Consult the immunology specialist regarding immunisation protocols; refrain from independent administration of live vaccines or substituting herbal advice for medical vaccination schedules.
- •Maintain rigorous hand hygiene, food safety standards, and sensible exposure precautions; ensure respiratory equipment is cleaned according to manufacturer instructions.
- •Maintain daily physiological regularity regarding nutrition, sleep, and moderate physical activity; monitor for objective changes in weight, fatigue levels, bowel function, or respiratory status.
Cautions & Contraindications
- •Do not substitute acupuncture or herbs for infection treatment or prescribed bronchiectasis airway clearance. The supplied bronchiectasis review describes integrated care, not replacement care.[]
- •Do not use COPD molecular targets or PLCG2 signalling findings to justify immune-stimulating herbs, genetic treatment claims or changes to immunoglobulin or immunosuppressive medicines; these abstracts do not establish such clinical applications.[,]
- •Do not infer that the jaw-rehabilitation review supports acupuncture, periarticular needling or injections for CVID-associated joint symptoms. New hot, swollen or acutely painful joints require medical assessment before local treatment; this precaution is not validated by that review.[]
When to reassess or seek care again
Record baseline fatigue on a 0–10 scale, cough severity, stool frequency, weight and daily function. Review any adjunctive trial within 2–4 weeks; stop or modify it if there is no meaningful symptom benefit or any adverse effect. Track infections and antibiotic use with the medical team, without attributing short-term changes to immune restoration. Refer promptly for worsening respiratory symptoms, persistent diarrhoea, new lymph-node enlargement, night sweats or weight loss; urgent red flags override the review interval.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Chinese medicine · 2026
- Frontiers in medicine · 2025
- BMC musculoskeletal disorders · 2025
- Journal of translational medicine · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
